Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2010 / Cilt: 20 - Sayı: 1

Mide kanserinde COX-2 ekspresyonu

COX-2 expression in gastric cancer

Pages
34–41
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, COX-2 expression in patients with gastric cancer was higher in tumor tissues than in adjacent tumor-free tissues.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We evaluated the cyclooxygenase-2 (COX-2) expression in the patients with gastric cancer in our region.
📊
Key Findings & Data:COX-2 expressions at the tumors and adjacent tissues were measured.
💡
Conclusion & Impact:In conclusion, COX-2 expression in patients with gastric cancer was higher in tumor tissues than in adjacent tumor-free tissues.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We evaluated the cyclooxygenase-2 (COX-2) expression in the patients with gastric cancer in our region. Twenty-six patients with gastric cancer were included into the study. Tissue samples were taken from the tumors and adjacent structures. Samples were histopathologically and immunohistochemically examined. COX-2 expressions at the tumors and adjacent tissues were measured. COX-2 was positive in 16 tumor positive tissues (61%) and negative in 6 tumor tissues (23%). There was a significant difference statistically between these two groups (p= 0.005). COX-2 was positive in 14 (63%) of 22 patients who had gastric cancer in intestinal type. COX-2 expression was also positive in 2 (50% ) of the remaining 4 cases with gastric cancer in diffuse type. COX-2 was positive in 5 (83%) of 6 well differentiated tumors, in 3 (37%) of 8 moderately differentiated tumors and in 8 (66%) of 12 poorly differentiated tumors. COX-2 was found positive in 5 (83%) of 6 cardia tumors and in 11 (55%) of 20 non-cardia tumors. In conclusion, COX-2 expression in patients with gastric cancer was higher in tumor tissues than in adjacent tumor-free tissues. There was no statistically significant association between COX2 expression and both histological type and differentiation of the tumors (p > 0.05).

Özet

Bu çalışmada bölgemizdeki mide kanserli olgularda siklooksijenaz-2 (COX- 2) salınımını araştırmak amaçlanmıştır. Çalışmaya endoskopik biyopsi ile mide kanseri tanısı konan 26 hasta (17 erkek, 9 bayan) alındı. Operasyon esnasında tümör ve tümöre komşu normal dokularından yaş doku örnekleri alındı. Örnekler histopatolojik olarak incelendi ve immunohistolojik yöntemle COX-2 antikoru ile boyanan dokular ışık mikroskobunda değerlendirildi. Tümör dokusu ve tümöre komşu normal dokuda COX-2 salınımı araştırıldı. COX-2 çalışmamızdaki 26 olgunun 16 tümör pozitif dokusunda (%61) pozitif iken, sadece 6 tümör negatif dokusunda (%23) pozitif bulundu. Bu iki grup arasında istatistiksel olarak anlamlı bir fark vardı (p= 0.005). ‹ntestinal tip mide kanseri olan 22 tümörün 14’ünde (%63) COX-2 pozitifti. Pozitif COX-2 salınımı geri kalan 4 diffüz tip mide kanserinin 2’sinde de (%50) gösterildi. COX-2 salınımı iyi diferansiye 6 tümörün 5’inde (%83), orta diferansiye 8 tümörün 3’ünde (%37) ve az diferansiye 12 tümörün 8’inde (%66) pozitifti. 6 kardia tümörünün 5’inde (%83) ve 20 kardia dışı tümörün 11’inde (%55) pozitif COX-2 salınımı bulundu. Sonuç olarak, çalışmada, mide kanserli hastalarda COX-2 salınımının tümöral dokularda, komşu tümöral olmayan normal dokulardakinden daha yüksek olduğunu gösterdik. Tümörün histolojik tipi ve diferensiasyon derecesi ile COX-2 salınımı arasında istatistiksel anlamlı ilişki tespit edilemedi (p > 0.05).

🔖

Cite This Article

BEKDEMİR, H., TEKİN, S. B., BİLİCİ, M., CAYIR, K., GÜNDOĞDU, C. (2010). Mide kanserinde COX-2 ekspresyonu. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 20 - Sayı: 1, 34–41. https://ajindex.com/articles/322995

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Karpeh MS, Kelsen DP, Teper JE. Cancer of the stomach. In: Cancer, Principles and Practice of Oncology. De Vita VT, Hellman S, Rosenburg SA eds. 6th. ed. Philadelphia, Lippincott-Raven, 2001: 1092-1126
  2. Kanserle Savaş Politikası ve Kanser Verileri (1995-1999), T.C.Sağlık Bakanlığı Kanserle Savaş Dairesi Başkanlığı, Bakanlık Yayın No: 618, 2002
  3. Sayek ‹. Temel Cerrahi. 1. baskı. Ankara, Güneş Kitabevi, 1991
  4. Sherman CD. Klinik Onkoloji. Türk Kanser Araştırma ve Savaş Kurumu Yayınları, 1990
  5. Reddy BS, Maruyama H, Kelloff G. Dose –related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflamatory drug, during different stages of rat colon tumour development. Cancer Res 47: 5340-5346, 1987
  6. Sawaoka H, Kawano S, Tsuji S, et al. Effects of NSA‹Ds on proliferation of gastric cancer cells in vitro: posible implication of cyclooxygenase-2 in cancer deve- lopmant. J Clin Gastroenterol 27: 47-52, 1998
  7. MasferrerJL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumour activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-1311, 2000
  8. Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 282: 1929-1933, 1999
  9. Lim JW, Kim H, Kim KH. Expression of ku 70 and ku 80 mediated by NF kappa B and COX-2 is related to proliferation of human gastric cancer cells. J Biol Chem 277: 46093-46100, 2002
  10. Saukkonen K, Rintahaka J, Sıvula A, et al. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 111: 915-925, 2003
  11. Saukkonen K, Nieminen O, Van Ress B, et al. Expression of Cyclooxygenase-2 in Dysplasia of the Stomach and in intestinal-type Gastric Adenocarcinoma. Clin Cancer Res 7: 1923-1931, 2001
  12. Lim H.Y, Joo H.J, Choi J.H, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 6: 519-525, 2000
  13. Ohno R, Yoshinaga K, Fujita T, et al. Dept of invasion parellels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91: 1876-1881, 2001
  14. Yamagata R, Shimoyama T, Fukuda S, et al. Cyclooxygenase-2 expression is increased in early intestinal type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol 14: 359-363, 2002
  15. Xue YW, Zhang QF, Zhu ZB, et al. Expression of cyclooxygenase-2 and clinocopathologic features in human gastric adenocarcinoma. World J Gastroenterol 9: 250-253, 2003
  16. Uefuji K, Ichikura T, Mochizuki H. Expression of c